Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, today announced a new strategic partnership with Syneos Health® (NASDAQ: SYNH), the only ...
Source: pharmiweb.com
